OraSure Technologies Inc
Change company Symbol lookup
Select an option...
OSUR OraSure Technologies Inc
FBBPF Prologis Property Mexico SA de CV
NRZ New Residential Investment Corp
BOMN Boston Omaha Corp
GLD SPDR® Gold Shares
GIS General Mills Inc
GILD Gilead Sciences Inc
GGN GAMCO Global Gold, Natural Resources & Income Trust
GGN GAMCO Global Gold, Natural Resources & Income Trust
GEF Greif Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap Blend
Company profile

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing.

Closing Price
$11.65
Day's Change
0.41 (3.65%)
Bid
--
Ask
--
B/A Size
--
Day's High
11.78
Day's Low
11.27
Volume
(Light)
Volume:
662,946

10-day average volume:
1,249,569
662,946

Display:

Providers:

UpdateCancel
6 providers
November 12, 2020
OraSure Technologies to Present at the Stephens Annual Investment Conference 2020

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the...(Globe Newswire)

November 04, 2020
OraSure Technologies, Inc. Announces Third Quarter 2020 Financial Results and Provides Update on COVID-19 Developments

Net Third Quarter Revenues of $48.0 Million Increased 33% Year-Over-Year, Driven by $18.4 Million in Sales of Oral Fluid Collection Devices for COVID-19 Molecular Testing Company Has Submitted EUA Application For Its Lab-based Oral Fluid SARS-CoV-2...(Globe Newswire)

OraSure Technologies, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 4, 2020 / OraSure Technologies, Inc. (NASDAQ:OSUR) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on November 4, 2020 at 5:00 PM Eastern Time. (Accesswire)

November 03, 2020
OraSure's DNA Genotek Subsidiary Receives FDA Emergency Use Authorization for its ORAcollect(R)-- RNA Saliva Collection Device for SARS CoV-2

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its DNA Genotek subsidiary has received Emergency Use...(Globe Newswire)

October 21, 2020
OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call Wednesday, November 4, 2020, 5:00 p.m. ET

OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2020 third quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, November 4, 2020. (Globe Newswire)

October 19, 2020
Thinking about buying stock in OraSure Technologies, AMC Entertainment, Can Fite Biopharma, American Airlines, or Canopy Growth Corp?

InvestorsObserver issues critical PriceWatch Alerts for OSUR, AMC, CANF, AAL, and CGC. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

OraSure's OMNIgene(R)-- ORAL Collection Device Receives FDA Emergency Use Authorization for SARS CoV-2

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its DNA Genotek subsidiary has received Emergency Use...(Globe Newswire)

September 24, 2020
OraSure's ORAcollect(R)-- RNA Device Included in EUA Granted to Quadrant Biosciences Inc. for COVID-19 Test

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that its ORAcollect(R)-- RNA (OR-100) saliva collection device...(Globe Newswire)

September 15, 2020
Former CEO of H2O+ Beauty, Former Chief Chemist of MAC Cosmetics Launch Innovative Skincare Brand Using First-Ever Scientific Microbiome Testing

Today, Joy Chen, former CEO of H2O+ Beauty, and Victor Casale, former Chief Chemist of MAC Cosmetics and co-founder of CoverFX, announced the launch of Pure Culture Beauty, the first skincare brand using data and science to deliver a comprehensive...(Globe Newswire)

September 04, 2020
Thinking about buying stock in OraSure Technologies, FuelCell Energy, Norwegian Cruise Line, Zynga Inc, or Nio Inc?

InvestorsObserver issues critical PriceWatch Alerts for OSUR, FCEL, NCLH, ZNGA, and NIO. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

September 03, 2020
OraSure's ORAcollect(R)-- RNA Device Included in EUA Granted to MiraDx Inc. for SARS-CoV-2 Test

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that its ORAcollect(R)-- RNA (OR-100) collection device was...(Globe Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.